Bromantane Reference

Plain English

What it is

Bromantane (brand name Ladasten) is a Russian-made compound described as an "actoprotector," a kind of synthetic adaptogen meant to help the body cope with stress and tiredness. It is a mild brain stimulant, not a peptide, and it is not approved by the FDA in the United States, where it is sold only as a research chemical.

What people use it for

People take it hoping for steadier focus, better mood, and more energy when they are run down or under stress. In Russia it is used for a condition called asthenia, which means ongoing weakness and fatigue.

What the science shows

Most of the human research is Russian-language clinical work reporting that it eases asthenia and anxiety and is generally well tolerated. Because it has not been studied or reviewed by US regulators, its benefits for healthy people remain largely unproven by Western standards.

The catch

It is not FDA-approved. The World Anti-Doping Agency bans it in competition as a stimulant, and several athletes tested positive for it at the 1996 Atlanta Olympics, so anyone in tested sport faces a doping risk.

Reference summary

Russian-language clinical literature on asthenia, fatigue, and stress recovery. Originally developed for the Soviet space program as an actoprotector.

Regulatory and posture

Categories

Nootropic

Aliases

Ladasten, ADK-709, Adamantylbromphenylamine

Evidence posture

human - Not FDA-approved in the US. Russian regulatory approval. WADA-prohibited under category S6 stimulants in competition (1996 Atlanta Olympics positive tests).

Regulatory status

No FDA-approved bromantane drug label. Russian-approved as Ladasten for asthenia. WADA prohibited bromantane after 1996 Atlanta Olympics positive tests; current WADA status: prohibited under category S6 stimulants in competition.

Content review status

research reference